Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of parkinson’s disease-lessons from transgenic mice

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · see citing works

The Inflammasome

Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066 · see citing works

The Inflammasomes

Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475 · see citing works

Parkinson's Disease

Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · see citing works

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · see citing works

GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons

Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206 · see citing works

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190 · see citing works

The prevalence of Parkinson's disease: a systematic review and meta-analysis

Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188 · see citing works

TNF-mediated inflammatory disease

Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094 · see citing works

Neuroinflammation in Parkinson’s disease: A target for neuroprotection?

Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984 · see citing works

Control of microglial neurotoxicity by the fractalkine receptor

Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531 · see citing works

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

Hyman, C., Hofer, M., Barde, Y., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,494 · see citing works

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,266 · see citing works

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

Javitch, J. A., D’Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,264 · see citing works

100 years of Lewy pathology

Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190 · see citing works

Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · see citing works

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease

Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172 · see citing works

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079 · see citing works

Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome

Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R. (2015) · Cell · doi:10.1016/j.cell.2014.11.047 · Cited by 1,014 · see citing works

Interleukin-1 and neuronal injury

Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992 · see citing works

Inflammasomes and Their Roles in Health and Disease

Lamkanfi, M., & Dixit, V. M. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155745 · Cited by 935 · cited 1× · see citing works

Historical insights into cytokines

Dinarello, C. A. (2007) · European Journal of Immunology · doi:10.1002/eji.200737772 · Cited by 926 · see citing works

Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP

Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 803 · see citing works

Glial reactions in Parkinson's disease

McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701 · see citing works

The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis

Schneider, A., Krüger, C., Steigleder, T., Weber, D., Pitzer, C., Laage, R., Aronowski, J. A., Maurer, M. H., Gaßler, N., Mier, W., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23559 · Cited by 691 · see citing works

Inflammasomes in the CNS

Walsh, J. G., Muruve, D. A., & Power, C. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3638 · Cited by 637 · cited 1× · see citing works

Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Jackson-Lewis, V. R., Jakowec, M. W., Burke, R. E., & Przedborski, S. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90015-2 · Cited by 609 · see citing works

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies

Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., & de Bernard, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055375 · Cited by 585 · see citing works

Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease

Sulzer, D. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.009 · Cited by 583 · see citing works

The parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP): a technical review of its utility and safety

Przedborski, S., Jackson-Lewis, V. R., Naini, A., Jakowec, M. W., Petzinger, G. M., Miller, R., & Akram, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00183.x · Cited by 507 · see citing works

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease

Berg, D., Postuma, R. B., Bloem, B. R., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G. M., Hardy, J., Lang, A. E., et al. (2014) · Movement Disorders · doi:10.1002/mds.25844 · Cited by 502 · see citing works

The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain

Russo, V. C., Gluckman, P. D., Feldman, E. L., & Werther, G. A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0024 · Cited by 488 · see citing works

In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining

Tatton, N. A., & Kish, S. J. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00545-3 · Cited by 469 · see citing works

Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts

Jellinger, K. A. (2011) · Movement Disorders · doi:10.1002/mds.23795 · Cited by 448 · see citing works

Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo

Lindholm, P., Voutilainen, M. H., Laurén, J., Peränen, J., Leppänen, V., Andressoo, J., Lindahl, M., Janhunen, S. K., Kalkkinen, N., Timmusk, T., et al. (2007) · Nature · doi:10.1038/nature05957 · Cited by 444 · see citing works

Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease

Reynolds, A. D., Banerjee, R., Liu, J., Gendelman, H. E., & Mosley, R. L. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507296 · Cited by 422 · see citing works

Neuroprotective Effect of Granulocyte Colony–Stimulating Factor After Focal Cerebral Ischemia

Schäbitz, W., Kollmar, R., Schwaninger, M., Jüettler, E., Bardutzky, J., Schölzke, M. N., Sommer, C., & Schwab, S. (2003) · Stroke · doi:10.1161/01.str.0000057814.70180.17 · Cited by 409 · see citing works

The Interferons: 50 Years after Their Discovery, There Is Much More to Learn*

Pestka, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700004200 · Cited by 405 · see citing works

α‐Synuclein Up‐Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP

Vila, M., Vukosavić, S., Jackson-Lewis, V. R., Neystat, M., Jakowec, M. W., & Przedborski, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740721.x · Cited by 388 · see citing works

The Neurotrophin Family of Neurotrophic Factors: An Overview

Skaper, S. D. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-536-7_1 · Cited by 379 · see citing works

The Inflammatory Reaction Following 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Intoxication in Mouse

Kurkowska‐Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6993 · Cited by 379 · see citing works

NLRP3 inflammasome is expressed and functional in mouse brain microglia but not in astrocytes

Gustin, A., Kirchmeyer, M., Koncina, E., Felten, P., Losciuto, S., Heurtaux, T., Tardivel, A., Heuschling, P., & Dostert, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130624 · Cited by 369 · see citing works

Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice

OTTO, D., & Unsicker, K. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-06-01912.1990 · Cited by 367 · see citing works

Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease

Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & O'Callaghan, J. P. (2002) · The FASEB Journal · doi:10.1096/fj.02-0216fje · Cited by 364 · see citing works

Premotor and nonmotor features of Parkinson's disease

Goldman, J. G., & Postuma, R. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000112 · Cited by 342 · see citing works

Chronic microglial activation and progressive dopaminergic neurotoxicity

Block, M. L., & Hong, J. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351127 · Cited by 324 · see citing works

1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles

Hasegawa, E., Takeshige, K., Oishi, T., Murai, Y., & Minakami, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90498-c · Cited by 320 · see citing works

Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP

Javitch, J. A., & Snyder, S. H. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90740-4 · Cited by 317 · see citing works

Involvement of Interferon-γ in Microglial-Mediated Loss of Dopaminergic Neurons

Mount, M. P., Lira, A., Grimes, D., Smith, P. D., Faucher, S., Slack, R. S., Anisman, H., Hayley, S. P., & Park, D. S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5321-06.2007 · Cited by 316 · see citing works

Interleukin 18 in the CNS

Alboni, S., Cervia, D., Sugama, S., & Conti, B. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-9 · Cited by 301 · see citing works

Neurochemical findings in the MPTP model of Parkinson's disease

Schmidt, N., & Ferger, B. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100004 · Cited by 290 · see citing works

Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Kohutnicka, M., Lewandowska, E., Kurkowska‐Jastrzębska, I., Członkowski, A., & Członkowska, A. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00022-8 · Cited by 283 · see citing works

Microglial Reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) Induced Parkinson's Disease Mice Model

Członkowska, A., Kohutnicka, M., Kurkowska‐Jastrzębska, I., & Członkowski, A. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0020 · Cited by 279 · see citing works

IV. MPTP, MPP+ and mitochondrial function

Nicklas, W. J., Youngster, S. K., Kindt, M. V., & Heikkila, R. E. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90299-2 · Cited by 257 · see citing works

MPTP Susceptibility in the Mouse: Behavioral, Neurochemical, and Histological Analysis of Gender and Strain Differences

Sedelis, M., Hofele, K., Auburger, G. W. J., Morgan, S., Huston, J. P., & Schwarting, R. K. W. (2000) · Behavior Genetics · doi:10.1023/a:1001958023096 · Cited by 253 · see citing works

IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease

Barcia, C., Ros, C., Annese, V., Gómez, A., Ros-Bernal, F., Aguado-Yera, D., Martı́nez-Pagán, M., de Pablos, V., Fernández-Villalba, E., & Herrero, M. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.17 · Cited by 242 · see citing works

Cytokines: Past, Present, and Future

Oppenheim, J. J. (2001) · International Journal of Hematology · doi:10.1007/bf02982543 · Cited by 236 · see citing works

Glial Cell Line-Derived Neurotrophic Factor Requires Transforming Growth Factor-β for Exerting Its Full Neurotrophic Potential on Peripheral and CNS Neurons

KRIEGLSTEIN, K. G., Henheik, P., Farkas, L. M., Jászai, J., Galter, D., Krohn, K., & Unsicker, K. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09822.1998 · Cited by 228 · see citing works

Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP‐induced neurotoxicity: role of TNF‐α 1

Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & O'Callaghan, J. P. (2006) · The FASEB Journal · doi:10.1096/fj.05-5106com · Cited by 224 · see citing works

Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat

Chiueh, C. C., Markey, S. P., Burns, R. S., Johannessen, J. N., Pert, A., & Kopin, I. J. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90221-8 · Cited by 224 · see citing works

Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine and 1‐Methyl‐4‐Phenylpyridinium Ion on Activities of the Enzymes in the Electron Transport System in Mouse Brain

Mizuno, Y., Sone, N., & Saitoh, T. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb05737.x · Cited by 222 · see citing works

Nigral pathology and parkinsonian signs in elders without Parkinson disease

Buchman, A. S., Shulman, J. M., Nag, S., Leurgans, S. E., Arnold, S. E., Morris, M. C., Schneider, J. A., & Bennett, D. A. (2011) · Annals of Neurology · doi:10.1002/ana.22588 · Cited by 213 · see citing works

Current advances in using neurotrophic factors to treat neurodegenerative disorders

Weissmiller, A. M., & Wu, C. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-14 · Cited by 211 · see citing works

Novel CDNF/MANF family of neurotrophic factors

Lindholm, P., & Saarma, M. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20760 · Cited by 193 · see citing works

MPTP: a review of its mechanisms of neurotoxicity

Przedborski, S., & Vila, M. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00019-6 · Cited by 191 · see citing works

Genetic ablation of tumor necrosis factor‐alpha (TNF‐α) and pharmacological inhibition of TNF‐synthesis attenuates MPTP toxicity in mouse striatum

Ferger, B., Leng, A., Mura, A., Hengerer, B., & Feldon, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02399.x · Cited by 187 · see citing works

TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice

Zhao, C., Ling, Z., Newman, M. B., Bhatia, A., & Carvey, P. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.012 · Cited by 183 · see citing works

Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease

Luchtman, D. W., Shao, D., & Song, C. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.04.021 · Cited by 167 · see citing works

A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey

Bézard, E., Imbert, C., Deloire, X., Bioulac, B. H., & Gross, C. E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00531-3 · Cited by 165 · see citing works

Glial Cell Line-Derived Neurotrophic Factor Is Essential for Postnatal Survival of Midbrain Dopamine Neurons

Granholm, A., Reyland, M. E., Albeck, D. S., Sanders, L., Gerhardt, G. A., Hoernig, G. R., Shen, L., Westphal, H., & Hoffer, B. J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03182.2000 · Cited by 160 · see citing works

ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo

Barcia, C., Ros, C. M., Annese, V., Carrillo-de Sauvage, M. A., Ros-Bernal, F., Gómez, A., Yuste, J. E., Campuzano, C. M., de Pablos, V., Fernandez-Villalba, E., et al. (2012) · Scientific Reports · doi:10.1038/srep00809 · Cited by 150 · see citing works

Granulocyte Colony‐Stimulating Factor and Granulocyte‐Macrophage Colony‐Stimulating Factor: Comparisons and Potential for Use in the Treatment of Infections in Nonneutropenic Patients

Root, R. K., & Dale, D. C. (1999) · The Journal of Infectious Diseases · doi:10.1086/513857 · Cited by 146 · see citing works

MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF)

Date, I., Notter, M. F. D., Felten, S. Y., & Felten, D. L. (1990) · Brain Research · doi:10.1016/0006-8993(90)90264-c · Cited by 145 · see citing works

Prevention of the Nigrostriatal Toxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine by Inhibitors of 3,4‐Dihydroxyphenylethylamine Transport

Mayer, R. A., Kindt, M. V., & Heikkila, R. E. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb00722.x · Cited by 138 · see citing works

CDNF Protects the Nigrostriatal Dopamine System and Promotes Recovery after MPTP Treatment in Mice

Airavaara, M., Harvey, B. K., Voutilainen, M. H., Shen, H., Chou, J., Lindholm, P., Lindahl, M., Tuominen, R. K., Saarma, M., Hoffer, B. J., et al. (2011) · Cell Transplantation · doi:10.3727/096368911x600948 · Cited by 135 · see citing works

The Soluble Isoform of CX3CL1 Is Necessary for Neuroprotection in a Mouse Model of Parkinson's Disease

Morganti, J. M., Nash, K. R., Grimmig, B. A., Ranjit, S., Small, B. J., Bickford, P. C., & Gemma, C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0539-12.2012 · Cited by 134 · see citing works

Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion

Chadi, G., Er, A., Rosén, L., Janson, A. M., Agnati, L. A., Goldstein, M., Ögren, S. O., Pettersson, R. F., & Fuxé, K. (1993) · Experimental Brain Research · doi:10.1007/bf00228825 · Cited by 133 · see citing works

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro

Rossetti, Z. L., Soroiut, A., Sharp, D. E., Hadjiconstantinou, M., & Neff, N. H. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90674-0 · Cited by 129 · see citing works

Repairing the parkinsonian brain with neurotrophic factors

Aron, L., & Klein, R. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.11.001 · Cited by 126 · see citing works

Granulocyte‐colony stimulating factor is neuroprotective in a model of Parkinson's disease

Meuer, K., Pitzer, C., Teismann, P., Krüger, C., Göricke, B., Laage, R., Lingor, P., Peters, K., Schlachetzki, J. C. M., Kobayashi, K., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03727.x · Cited by 121 · see citing works

Interferons in the central nervous system: A few instruments play many tunes

Owens, T., Khorooshi, R., Włodarczyk, A., & Asgari, N. (2013) · Glia · doi:10.1002/glia.22608 · Cited by 119 · see citing works

GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice

Kosloski, L. M., Kosmacek, E. A., Olson, K. E., Mosley, R. L., & Gendelman, H. E. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.10.009 · Cited by 119 · see citing works

Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice

Wang, X., Zhai, Y., Xu, L., Qiao, C., Sun, X., Ding, J., Lu, M., & Hu, G. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.001 · Cited by 112 · see citing works

Glial Cell Line-Derived Neurotrophic Factor Rescues Target-Deprived Sympathetic Spinal Cord Neurons But Requires Transforming Growth Factor-β as CofactorIn Vivo

Schober, A., Hertel, R., Arumäe, U., Farkas, L. M., Jászai, J., KRIEGLSTEIN, K. G., Saarma, M., & Unsicker, K. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-06-02008.1999 · Cited by 110 · see citing works

MPTP-Induced Neuroinflammation Increases the Expression of Pro-Inflammatory Cytokines and Their Receptors in Mouse Brain

Lofrumento, D. D., Saponaro, C., Cianciulli, A., Nuccio, F. D., Mitolo, V., Nicolardi, G., & Panaro, M. A. (2010) · NeuroImmunoModulation · doi:10.1159/000320027 · Cited by 109 · see citing works

Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones

Boyce, S., Kelly, E., Reavill, C. A., Jenner, P. G., & MARSDEN, C. D. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90344-7 · Cited by 108 · see citing works

Macrophage-mediated GDNF Delivery Protects Against Dopaminergic Neurodegeneration: A Therapeutic Strategy for Parkinson's Disease

Biju, K. C., Zhou, Q., Li, G., Imam, S. Z., Roberts, J. L., Morgan, W. W., Clark, R. A., & Li, S. (2010) · Molecular Therapy · doi:10.1038/mt.2010.107 · Cited by 106 · see citing works

Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture

Nikkhah, G., Odin, P., Smits, A. M., Tingstr�m, A., Othberg, A. I., Brundin, P., Funa, K., & Lindvall, O. (1993) · Experimental Brain Research · doi:10.1007/bf00229041 · Cited by 103 · see citing works

Increased vulnerability of dopaminergic neurons in MPTP‐lesioned interleukin‐6 deficient mice

Bolin, L., Strycharska-Orczyk, I., Murray, R., Langston, J., & Monte, D. D. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01131.x · Cited by 95 · see citing works

Role of TNF-α Receptors in Mice Intoxicated with the Parkinsonian Toxin MPTP

Rousselet, E., Callebert, J., Parain, K., Joubert, C., Hunot, S., Hartmann, A., Jacque, C., Pérez-Díaz, F., Cohen‐Salmon, C., Launay, J., et al. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7960 · Cited by 90 · see citing works

GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-β for its neuroprotective action

Schober, A., Peterziel, H., von Bartheld, C. S., Simon, H. H., KRIEGLSTEIN, K. G., & Unsicker, K. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.005 · Cited by 86 · see citing works

Parkinson's disease and age: The obvious but largely unexplored link

Abdullah, R., Basak, I., Patil, K. S., Alves, G. W., Larsen, J. P., & Møller, S. G. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.014 · Cited by 85 · see citing works

Epidermal Growth Factor Enhances Striatal Dopaminergic Parameters in the 1‐Methyl‐4‐Phenyl‐l, 2, 3, 6‐Tetrahydropyridine‐Treated Mouse

Hadjiconstantinou, M., Fitkin, J. G., Dalia, A., & Neff, N. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03776.x · Cited by 82 · see citing works

Transgenic mice expressing a dominant negative mutant interleukin-1β converting enzyme show resistance to MPTP neurotoxicity

Klivènyi, P., Andreassen, O. A., Ferrante, R. J., Schleicher, J. R., Friedlander, R. M., & Beal, M. F. (1999) · Neuroreport · doi:10.1097/00001756-199902250-00035 · Cited by 80 · see citing works

Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration

Baydyuk, M., Nguyen, M. T., & Xu, B. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.12.018 · Cited by 80 · see citing works

Chemokines in the MPTP model of Parkinson’s disease: Absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration

Kalkonde, Y. V., MORGAN, W. W., Sigala, J. A., Maffi, S. K., Condello, C., Kuziel, W. A., Ahuja, S. S., & Ahuja, S. K. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.041 · Cited by 75 · see citing works

The effects of MPTP on the activation of microglia/astrocytes and cytokine/chemokine levels in different mice strains

Yasuda, Y. U., Shimoda, T., Uno, K., Tateishi, N., Furuya, S., Yagi, K., Suzuki, K., & Fujita, S. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.08.003 · Cited by 73 · see citing works

Restorative Effects of Platelet Derived Growth Factor-BB in Rodent Models of Parkinson's Disease

Zachrisson, O., Zhao, M., Andersson, A., Dannaeus, K., Häggblad, J., Isacson, R., Nielsen, E. I., Patrone, C., Rönnholm, H., Wikström, L., et al. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-0003 · Cited by 71 · see citing works

Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson’s disease

Pattarini, R., Smeyne, R. J., & Morgan, J. I. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.030 · Cited by 70 · see citing works

Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity

Zompo, M. D., Piccardi, M. P., Ruiu, S., Quartu, M., GESSA, G. L., & Vaccari, A. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13584.x · Cited by 69 · see citing works

Dynamics of expression of the mRNA for cytokines and inducible nitric synthase in a murine model of the Parkinson's disease

Ciesielska, A., Joniec‐Maciejak, I., Przybyłkowski, A. M., Gromadzka, G., Iwona, Członkowska, A., & Członkowski, A. (2003) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2003-1461 · Cited by 68 · see citing works

Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice

Cardenas, H., & Bolin, L. M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03172-x · Cited by 67 · see citing works

Erratum: IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson’s disease

Barcia, C., Ros, C. M., Annese, V., Gómez, A. M., Ros‐Bernal, F., Aguado‐Llera, D., Martínez-Pagán, M. E., de Pablos, V., Fernández‐Villalba, E., & Herrero, M. T. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.123 · Cited by 67 · see citing works

Redox cycling of MPP+: Evidence for a new mechanism involving hydride transfer with xanthine oxidase, aldehyde dehydrogenase, and lipoamide dehydrogenase

Klaidman, L. K., Adams, J. D., Jr., Leung, A. C., Kim, S. S., & Cadenas, E. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90056-z · Cited by 66 · see citing works

Specific effects of platelet derived growth factor (PDGF) on fetal rat and human dopaminergic neurons in vitro

Othberg, A. I., Odin, P., Ballagi, A. E., Åhgren, A., Funa, K., & Lindvall, O. (1995) · Experimental Brain Research · doi:10.1007/bf00242187 · Cited by 66 · see citing works

Neuroinflammation in Parkinson’s patients and MPTP-treated mice is not restricted to the nigrostriatal system: Microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb

Vroon, A., Drukarch, B., Bol, J. G. J. M., Cras, P. P., Brevé, J. J. P., Allan, S. M., Relton, J. K., Hoogland, P. V. J. M., & van Dam, A. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.04.010 · Cited by 66 · see citing works

RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals

Kowsky, S., Pöppelmeyer, C., Kramer, E. R., Falkenburger, B. H., Kruse, A., Klein, R., & Schulz, J. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706177104 · Cited by 65 · see citing works

Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment

Sugama, S., Wirz, S., Barr, A. M., Conti, B., Bartfai, T., & Shibasaki, T. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.020 · Cited by 63 · see citing works

Granulocyte–macrophage colony‐stimulating factor promotes survival of dopaminergic neurons in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced murine Parkinson’s disease model

Kim, N. K., Choi, B. H., Huang, X., Snyder, B., Bukhari, S., Kong, T., Park, H., Park, H. C., Park, S. R., & Ha, Y. S. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06653.x · Cited by 62 · see citing works

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson′s disease

O’Keeffe, G. W., Sullivan, A. M., & Hegarty, S. V. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.143410 · Cited by 57 · see citing works

GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice

Date, I., Aoi, M., Tomita, S., Collins, F., & Ohmoto, T. (1998) · Neuroreport · doi:10.1097/00001756-199807130-00039 · Cited by 54 · see citing works

Exercise does not protect against MPTP-induced neurotoxicity in BDNF happloinsufficent mice

Gerecke, K. M., Jiao, Y., Pagala, V., & Smeyne, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043250 · Cited by 53 · see citing works

Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice

Cheng, F., Ni, D.-R., Wu, M., Kuo, J., & Chia, L. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00554-0 · Cited by 50 · see citing works

Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration

Choi, D., Lee, M. K., & Hong, J. T. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.08.001 · Cited by 49 · see citing works

Localization of nerve growth factor, neurotrophin-3, and glial cell line-derived neurotrophic factor in nestin-expressing reactive astrocytes in the caudate-putamen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/Bl mice

Chen, L.-W., Zhang, J., Shum, D. K., & Chan, Y. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21014 · Cited by 47 · see citing works

Recombinant human granulocyte colony‐stimulating factor protects against MPTP‐induced dopaminergic cell death in mice by altering Bcl‐2/Bax expression levels

Cao, X., Arai, H., Ren, Y., Oizumi, H., Zhang, N., Seike, S., Furuya, T., Yasuda, T., Mizuno, Y., & Mochizuki, H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04125.x · Cited by 46 · see citing works

Ventricular injection of nerve growth factor increases dopamine content in the striata of MPTP-treated mice

Garcı́a, E., Rı́os, C., & Sotelo, J. (1992) · Neurochemical Research · doi:10.1007/bf00966824 · Cited by 44 · see citing works

Bone marrow-derived microglia-based neurturin delivery protects against dopaminergic neurodegeneration in a mouse model of Parkinson's disease

Biju, K. C., Santacruz, R. A., Chen, C., Zhou, Q., Yao, J., Rohrabaugh, S., Clark, R. A., Roberts, J. L., Phillips, K. A., Imam, S. Z., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2012.12.034 · Cited by 44 · see citing works

Tumor necrosis factor-alpha receptor ablation in a chronic MPTP mouse model of Parkinson's disease

Leng, A., Mura, A., Feldon, J., & Ferger, B. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.077 · Cited by 43 · see citing works

Neurorestoration

Airavaara, M., Voutilainen, M. H., Wang, Y., & Hoffer, B. J. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70045-1 · Cited by 40 · see citing works

IGF-1 signaling reduces neuro-inflammatory response and sensitivity of neurons to MPTP

Nadjar, A., Berton, O., Guo, S., Leneuve, P., Doveró, S., Diguet, E., Tison, F., Zhao, B., Holzenberger, M., & Bézard, E. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.009 · Cited by 39 · see citing works

FGF‐2 Modulates Dopamine and Dopamine‐related Striatal Transmitter Systems in the Intact and MPTP‐lesioned Mouse

Otto, D., & Unsicker, K. (1993) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1993.tb00943.x · Cited by 37 · see citing works

FGF‐2 in the MPTP model of parkinson's disease: Effects on astroglial cells

Otto, D., & Unsicker, K. (1994) · Glia · doi:10.1002/glia.440110107 · Cited by 36 · see citing works

Transforming growth factor $beta;1 overexpression in the nigrostriatal system increases the dopaminergic deficit of MPTP mice

Sánchez‐Capelo, A. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00081-2 · Cited by 35 · see citing works

Transforming growth factor beta2 haploinsufficient mice develop age-related nigrostriatal dopamine deficits

Andrews, Z. B., Zhao, H., Frugier, T., Meguro, R., Grattan, D. R., Koishi, K., & McLennan, I. S. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.001 · Cited by 35 · see citing works

Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Yasuda, Y. U., Shinagawa, R., Yamada, M., Mori, T. A., Tateishi, N., & Fujita, S. (2006) · Brain Research · doi:10.1016/j.brainres.2006.12.054 · Cited by 35 · see citing works

Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFRα1, gene

Boger, H. A., Middaugh, L. D., Zaman, V., Hoffer, B. J., & Granholm, A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.09.011 · Cited by 32 · see citing works

Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice

Chen, L.-W., Hu, H., Liu, L., Yung, K. K. L., & Chan, Y. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.04.020 · Cited by 32 · see citing works

Neurotrophic factors in neurodegenerative disorders: Model of parkinson’s disease

de Yébenes, J. G., & Mena, M. A. (2000) · Neurotoxicity Research · doi:10.1007/bf03033789 · Cited by 31 · see citing works

Evidence for resistance to MPTP in C57BL/6 × BALA/c F1 hybrids as compared with their progenitor strains

Sedelis, M., Hofele, K., Auburger, G. W. J., Morgan, S., Huston, J. P., & Schwarting, R. K. W. (2000) · Neuroreport · doi:10.1097/00001756-200004070-00037 · Cited by 30 · see citing works

Development of mesencephalic dopaminergic neurons and the transforming growth factor-beta superfamily.

Krieglstein, K., Suter‐Crazzolara, C., & Unsicker, K. (1995) · PubMed · Cited by 30 · see citing works

Early Effects of FGF-2 on Glial Cells in the MPTP-Lesioned Striatum

Wirth, S. B., Rufer, M., & Unsicker, K. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0018 · Cited by 20 · see citing works

Granulocyte-colony stimulating factor (G-CSF) enhances recovery in mouse model of Parkinson's disease

Song, S., Sava, V., Rowe, A. R., Li, K., Cao, C., Mori, T., & Sanchez‐Ramos, J. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.10.012 · Cited by 18 · see citing works

FGF‐2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice

Zechel, S., Jarosik, J., Kiprianova, I., Schober, A., Unsicker, K., & Halbach, O. V. B. U. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04700.x · Cited by 15 · see citing works

A role of IL-1 in MPTP-induced changes in striatal dopaminergic and serotoninergic transporter binding: clues from interleukin-1 type I receptor-deficient mice

Hébert, G. A., Mingam, R., Arsaut, J., Dantzer, R., & Demotes‐Mainard, J. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.01.009 · Cited by 6 · see citing works

Microglia in physiology and disease

Wolf, S. A., Boddeke, H. W. G. M., & Kettenmann, H. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034406 · Cited by 1,426 · see citing works

LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease

Heckmann, B. L., Teubner, B. J. W., Tummers, B., Boada-Romero, E., Harris, L., Yang, M., Guy, C. S., Zakharenko, S. S., & Green, D. R. (2019) · Cell · doi:10.1016/j.cell.2019.05.056 · Cited by 503 · see citing works

Microbiome–microglia connections via the gut–brain axis

Abdel-Haq, R., Schlachetzki, J. C. M., Glass, C. K., & Mazmanian, S. K. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180794 · Cited by 471 · see citing works

MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration

Lee, E., Hwang, I., Park, S., Hong, S., Hwang, B., Cho, Y., Son, J., & Yu, J.-W. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0124-5 · Cited by 431 · see citing works

Aging Microglia—Phenotypes, Functions and Implications for Age-Related Neurodegenerative Diseases

Spittau, B. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00194 · Cited by 258 · see citing works

Silencing of TGFβ signalling in microglia results in impaired homeostasis

Zöller, T., Schneider, A., Kleimeyer, C., Masuda, T., Potru, P. S., Pfeifer, D., Blank, T., Prinz, M., & Spittau, B. (2018) · Nature Communications · doi:10.1038/s41467-018-06224-y · Cited by 189 · see citing works

Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia

Eshraghi, M., Adlimoghaddam, A., Mahmoodzadeh, A., Sharifzad, F., Yasavoli-Sharahi, H., Lorzadeh, S., Albensi, B. C., & Ghavami, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073330 · Cited by 158 · see citing works

Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases

Staff, N. P., Jones, D. T., & Singer, W. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.01.001 · Cited by 150 · see citing works

Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson’s Disease?

Herrera, A., Muñoz, P., Steinbusch, H. W. M., & Segura‐Aguilar, J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00034 · Cited by 135 · see citing works

LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia

Kim, J., Pajarillo, E. A. B., Rizor, A., Son, D., Lee, J., Aschner, M., & Lee, E.-S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210248 · Cited by 89 · see citing works

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson’s Disease

Huang, D., Xu, J., Wang, J., Tong, J., Bai, X., Li, H., Wang, Z., Huang, Y., Wu, Y., Yu, M., et al. (2017) · Parkinson s Disease · doi:10.1155/2017/9349487 · Cited by 86 · see citing works

DNA Methylation and Expression Profiles of Whole Blood in Parkinson’s Disease

Henderson, A., Wang, Q., Meechoovet, B., Siniard, A., Naymik, M., Both, M. D. D., Huentelman, M., Caselli, R., Driver-Dunckley, E., & Dunckley, T. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.640266 · Cited by 68 · see citing works

Hesperidin Ameliorates Anxiety-Depressive-Like Behavior in 6-OHDA Model of Parkinson’s Disease by Regulating Striatal Cytokine and Neurotrophic Factors Levels and Dopaminergic Innervation Loss in the Striatum of Mice

Antunes, M. S., Souza, L. C., Ladd, F. V. L., Ladd, A. A. B. L., Moreira, A. L., Bortolotto, V. C., Poetini, M. R., Araújo, S. M., Prigol, M., Nogueira, C. W., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01940-3 · Cited by 75 · see citing works

Divergent Effects of Metformin on an Inflammatory Model of Parkinson’s Disease

Tayara, K., Espinosa‐Oliva, A. M., García-Domínguez, I., Ismaiel, A. A., Boza‐Serrano, A., Deierborg, T., Machado, A., Herrera, A. J., Venero, J. L., & de Pablos, R. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00440 · Cited by 66 · see citing works

Mesenchymal stem cells enhance microglia M2 polarization and attenuate neuroinflammation through TSG-6

Liu, Y., Zeng, R., Wang, Y., Huang, W., Hu, B., Zhu, G., Zhang, R., Li, F., Han, J., & Li, Y. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146422 · Cited by 60 · see citing works

Naringenin targets on astroglial Nrf2 to support dopaminergic neurons

Wang, G., Zhang, B., He, X., Li, D., Shi, J., & Zhang, F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.043 · Cited by 55 · see citing works

Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson’s disease

Li, Q., Shen, C., Liu, Z., Ma, Y., Wang, J., Dong, H., Zhang, X., Wang, Z., Yu, M., Ci, L., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.13094 · Cited by 50 · see citing works

Wiring and Volume Transmission: An Overview of the Dual Modality for Serotonin Neurotransmission

Gianni, G., & Pasqualetti, M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00648 · Cited by 44 · see citing works

GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment

Mendes‐Oliveira, J., Campos, F. L., Videira, R. A., & Baltazar, G. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.04.016 · Cited by 46 · see citing works

Neuroinflammation in CNS diseases: Molecular mechanisms and the therapeutic potential of plant derived bioactive molecules

Welcome, M. O. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100176 · Cited by 41 · see citing works

Small molecule modulator of aggrephagy regulates neuroinflammation to curb pathogenesis of neurodegeneration

Suresh, S. N., Pandurangi, J., Murumalla, R. K., Vidyadhara, D. J., Garimella, L., Acharya, A., Rai, S., Paul, A., Yarreiphang, H., Pillai, M. S., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.036 · Cited by 40 · see citing works

SIRT1 attenuates neuroinflammation by deacetylating HSPA4 in a mouse model of Parkinson's disease

Yang, Y., Zhang, S., Guan, J., Jiang, Y., Zhang, J., Luo, L., & Sun, C. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166365 · Cited by 39 · see citing works

Curcumin protects against rotenone-induced Parkinson's disease in mice by inhibiting microglial NLRP3 inflammasome activation and alleviating mitochondrial dysfunction

Xu, L., Hao, L.-P., Yu, J., Cheng, S.-Y., Fan, L., Ding, S.-M., & Zhang, R. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16195 · Cited by 36 · see citing works

Aged-Related Changes in Microglia and Neurodegenerative Diseases: Exploring the Connection

Borrajo, A. (2024) · Biomedicines · doi:10.3390/biomedicines12081737 · Cited by 36 · see citing works

Inhibition of macrophage migration inhibitory factor ( MIF ) tautomerase activity suppresses microglia‐mediated inflammatory responses

Zhang, Y., Gu, R., Jia, J., Hou, T., Zheng, L. T., & Zhen, X. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12647 · Cited by 34 · see citing works

Protective effects of a herbal extract combination of Bupleurum falcatum , Paeonia suffruticosa , and Angelica dahurica against MPTP-induced neurotoxicity via regulation of nuclear receptor-related 1 protein

Sim, Y., Park, G., Eo, H., Huh, E., Gu, P. S., Hong, S.-P., Pak, Y. K., & Oh, M. S. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.10.029 · Cited by 33 · see citing works

Therapeutic potential of GDNF in neuroinflammation: Targeted delivery approaches for precision treatment in neurological diseases

Singh, G., Sikder, A., Phatale, V., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104876 · Cited by 31 · see citing works

Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson’s Disease

Ma, Y., & Rong, Q. (2022) · Contrast Media & Molecular Imaging · doi:10.1155/2022/2112146 · Cited by 29 · see citing works

Interleukin-4 Protects Dopaminergic Neurons In vitro but Is Dispensable for MPTP-Induced Neurodegeneration In vivo

Hühner, L., Rilka, J., Gilsbach, R., Zhou, X., Machado, V., & Spittau, B. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00062 · Cited by 25 · see citing works

Interleukin 4-induced neuroprotection and regulation of microglia activation as a therapeutic approach in the MPTP model of Parkinson's disease

Spittau, B. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.215250 · Cited by 23 · see citing works

Microglia depletion prior to lipopolysaccharide and paraquat treatment differentially modulates behavioral and neuronal outcomes in wild type and G2019S LRRK2 knock-in mice

Dwyer, Z., Rudyk, C., Situt, D., Beauchamp, S., Abdali, J., Dinesh, A., Legancher, N., Sun, H., Schlossmacher, M. G., & Hayley, S. P. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100079 · Cited by 20 · see citing works

Activation of microglia synergistically enhances neurodegeneration caused by MPP+ in human SH-SY5Y cells

Peng, Z., Luchtman, D. W., Wang, X., Zhang, Y., & Song, C. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.01.024 · Cited by 19 · see citing works

Restoration of Parkinson’s Disease-Like Deficits by Activating Autophagy through mTOR-Dependent and mTOR-Independent Mechanisms in Pharmacological and Transgenic Models of Parkinson’s Disease in Mice

Pupyshev, A. B., Tenditnik, M. V., Ovsyukova, M. V., Akopyan, A. A., Dubrovina, N. I., & Tikhonova, M. A. (2021) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-021-05242-z · Cited by 18 · see citing works

Minocycline effects on memory and learning impairment in the beta-amyloid-induced Alzheimer’s disease model in male rats using behavioral, biochemical, and histological methods

Mahmoudian, Z. G., Ghanbari, A., Rashidi, I., Amiri, I., & Komaki‬, A. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175784 · Cited by 18 · see citing works

Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species

Soto‐Díaz, K., Vailati-Riboni, M., Louie, A. Y., McKim, D. B., Gaskins, H. R., Johnson, R. W., & Steelman, A. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.734349 · Cited by 18 · see citing works

Physiological Concentration of H2O2 Supports Dopamine Neuronal Survival via Activation of Nrf2 Signaling in Glial Cells

Wang, G., Yang, Q., Zheng, C.-Q., Li, D., Li, J., & Zhang, F. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00844-z · Cited by 16 · see citing works

Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson’s disease

Kostrzewa, R. M. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02479-4 · Cited by 16 · see citing works

Assessment of CRISPRa-mediated gdnf overexpression in an In vitro Parkinson’s disease model

Guzmán-Sastoque, P., Sotelo, S., Esmeral, N. P., Albarracín, S. L., Sutachan, J. J., Reyes, L. H., Muñoz-Camargo, C., Cruz, J. C., & Bloch, N. I. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1420183 · Cited by 15 · see citing works

Glial cells improve Parkinson’s disease by modulating neuronal function and regulating neuronal ferroptosis

Li, M., Chen, M., Li, H., Gao, D., Zhao, L., & Zhu, M. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1510897 · Cited by 15 · see citing works

In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease

Rizzi, N., Brunialti, E., Cerri, S., Cermisoni, G. C., Levandis, G., Cesari, N., Maggi, A. C., Blandini, F., & Ciana, P. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.02.005 · Cited by 14 · see citing works

Modulation of microglia activation and Alzheimer's disease

Suresh, P., Phasuk, S., & Liu, I. Y. (2021) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_144_20 · Cited by 14 · see citing works

Targeted Ablation of Primary Cilia in Differentiated Dopaminergic Neurons Reduces Striatal Dopamine and Responsiveness to Metabolic Stress

Mustafa, R., Rawas, C., Mannal, N., Kreiner, G., Spittau, B., Kamińska, K., Yilmaz, R., Pötschke, C., Kirsch, J., Liss, B., et al. (2021) · Antioxidants · doi:10.3390/antiox10081284 · Cited by 13 · see citing works

Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson’s Disease

Šaponjić, J., Mejı́as, R., Nikolovski, N., Dragić, M., Canak, A., Papoutsopoulou, S., Özdemir, Y., Fladmark, K. E., Ntavaroukas, P., Muluk, N. B., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084330 · Cited by 13 · see citing works

P2Y12 receptor-mediated microglia activation involved in delayed encephalopathy after acute carbon monoxide poisoning

Xiang, W., Yang, Z., Xue, H., Wang, J., Niu, F., Wang, J., Chen, C., Wang, Y., Pang, J., & Wang, B. (2021) · Aging · doi:10.18632/aging.202607 · Cited by 13 · see citing works

Rational design, synthesis and activities of hydroxylated chalcones as highly potent dual functional agents against Alzheimer's disease

Liu, Y., Han, C., Dai, R., & Li, B. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105662 · Cited by 12 · see citing works

Lipopolysaccharide-Induced Microglia Activation Promotes the Survival of Midbrain Dopaminergic Neurons In Vitro

Zhou, X., & Spittau, B. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9842-6 · Cited by 12 · see citing works

The research advances in the mechanism of manganese-induced neurotoxicity

Li, J., Cen, Y., & Li, Y. (2018) · Toxin Reviews · doi:10.1080/15569543.2018.1486859 · Cited by 11 · see citing works

Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson’s Disease

Serrano-Martínez, I., Pedreño, M., Castillo-González, J., Ferraz-de-Paula, V., Vargas-Rodríguez, P., Forte‐Lago, I., Caro, M., Campos‐Salinas, J., Villadiego, J., Peñalver, P., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020694 · Cited by 9 · see citing works

Nigrostriatal Inflammation Is Associated with Nonmotor Symptoms in an Experimental Model of Prodromal Parkinson’s Disease

Oliveira, B. D. S., Toscano, E. C. D. B., Abreu, L. K. S., Fernandes, H. D. B., Amorim, R. F., Ferreira, R. N., Machado, C. A., Carvalho, B. C., da Silva, M. C. M., de Oliveira, A. C. P., et al. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.05.011 · Cited by 10 · see citing works

Recent Progress in the Drug Development for the Treatment of Alzheimer’s Disease Especially on Inhibition of Amyloid-peptide Aggregation

Liu, Y., Cong, L., Han, C., Li, B., & Dai, R. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666201127104539 · Cited by 10 · see citing works

Comparing the effect of intravenous versus intracranial grafting of mesenchymal stem cells against parkinsonism in a rat model: Behavioral, biochemical, pathological and immunohistochemical studies

Essawy, A. E., Abou-ElNaga, O. A., Mehanna, R. A., Badae, N. M., Sheta, E., & Soffar, A. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296297 · Cited by 9 · see citing works

What have we learned recently from transgenic mouse models about neurodegeneration? The most promising discoveries of this millennium

Kreiner, G. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.09.006 · Cited by 9 · see citing works

Milk and Parkinson disease: Could galactose be the missing link

Sarni, A. R., & Baroni, L. (2018) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-180234 · Cited by 10 · see citing works

2,4-Dichlorophenoxyacetic Acid Induces Degeneration of mDA Neurons In Vitro

Ruß, T., Enders, L., Zbiegly, J. M., Potru, P. S., Wurm, J., & Spittau, B. (2023) · Biomedicines · doi:10.3390/biomedicines11112882 · Cited by 8 · see citing works

Molecular intersections of traumatic brain injury and Alzheimer’s disease: the role of ADMSC-derived exosomes and hub genes in microglial polarization

Li, P., Ye, L., Sun, S., Wang, Y., Chen, Y., Chang, J., Yin, R., Liu, X., Zuo, W., Xu, H., et al. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01503-8 · Cited by 7 · see citing works

Extraction of malva sylvestris seed oil by soxhlet method and alginate/chitosan microencapsulation with a new method: Investigation of its cytotoxic effects on human neuroblastoma cell line (SH-SY5Y)

Ulusal, H., Ulusal, F., Dağlı, S., & Toprak, C. (2024) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2024.100875 · Cited by 6 · see citing works

Low-dose ciprofol attenuates motor dysfunction in PD mice by inhibiting NLRP3 inflammasome activation

Wang, Y., Li, M., Li, Y., Guo, J., Huo, X., Gao, J., & Wang, H. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115826 · Cited by 5 · see citing works

Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson’s disease

Menna, L. D., Alborghetti, M., Bartolo, M. I. D., Borro, M., Gentile, G., Zinni, M., Bologna, M., Cutrona, C., D’Errico, G., Imbriglio, T., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-024-00860-6 · Cited by 5 · see citing works

CDNF overexpression prevents motor-cognitive dysfunction by intrastriatal CPP-based delivery system in a Parkinson's disease animal model.

Villa-Cedillo, S. A., Matta-Yee-Chig, D., Soto-Domínguez, A., Rodríguez-Rocha, H., García-García, A., Montes-de-Oca-Saucedo, C., Loera-Arias, M. D. J., Valdés, J., & Saucedo-Cárdenas, O. (2023) · Neuropeptides · doi:10.1016/j.npep.2023.102385 · Cited by 4 · see citing works

LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models

Acton, S. L., Donnell, M. M. O., Periyasamy, K., Dixit, B., Eishingdrelo, H., Hill, C., Ross, R. P., & Chesnel, L. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.08.024 · Cited by 5 · see citing works

Isoquercetin mitigates neuroinflammation and oxidative stress by targeting the NF-κB pathway

Kaur, D., & Singh, S. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150004 · Cited by 4 · see citing works

Therapeutic potential of mesenchymal stem cells in neurodegenerative diseases

Cui, C.-X., Shao, X.-N., Li, Y., Qiao, L., Lin, J., & Guan, L. (2025) · World Journal of Stem Cells · doi:10.4252/wjsc.v17.i8.107717 · Cited by 4 · see citing works

Neuroprotective Effects Exerted by a Combination of Selected Lactic Acid Bacteria in a Mouse Parkinsonism Model under Levodopa-Benserazide Treatment

Visñuk, D. P., LeBlanc, J. G., & de LeBlanc, A. D. M. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04217-6 · Cited by 4 · see citing works

Deletion of ZNRF2 Exacerbates MPTP-Induced Parkinson’s Disease by Activating mTOR-Mediated Neuroinflammatory Pathways

Zhang, F., Xu, J., Yuan, Q., Xie, Y., Zhang, L., Zhang, J., Xu, Z., & Liu, M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05044-8 · Cited by 2 · see citing works

Neuroinflammation-mediated white matter injury in Parkinson’s disease and potential therapeutic strategies targeting NLRP3 inflammasome

Xiao, L., Wang, M., Shi, Y., Huang, X., Zhang, W., Wu, Y., Deng, H., Xiong, B., Pan, W., Zhang, J., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113483 · Cited by 2 · see citing works

Multi-Atlas Segmentation of Mouse Brain MRM Based on Optimized Advanced Normalization Tools

Lan, L. (2017) · Science Discovery · doi:10.11648/j.sd.20170506.26 · Cited by 2 · see citing works

Adverse Outcome Pathway on chronic binding of antagonist to N-methyl-D-aspartate receptors during brain development leading to neurodegeneration with impairment in learning and memory in aging

Monnet‐Tschudi, F., & FitzGerald, R. (2018) · OECD series on adverse outcome pathways · doi:10.1787/95f569ad-en · Cited by 3 · see citing works

Pharmacological and Nutritional Approaches to Modulate Microglial Polarization in Cognitive Senescence

Ponnusamy, B., Rajagopal, P., & Jayaraman, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_12 · Cited by 1 · see citing works

Neuron Foundry Mach 8: A Concept of Multi-modal Neuro-supportive Energy Therapy Device for Treating Neurodegenerative Disorders

McGlynn, C., Dermawan, D., & Canonizado, G. M. (2024) · Brain Science Advances · doi:10.26599/bsa.2023.9050026 · Cited by 1 · see citing works

Environmental Medicine

Pizzorno, J. E., & Crinnion, W. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00035-2 · Cited by 1 · see citing works

Environmental toxicant exposure and Parkinson’s disease: LRRK2 and inflammatory processes

Dwyer, Z. (2019) · doi:10.22215/etd/2019-13709

A role for LRRK2 and Neuroinflammatory Processes in Multi-Hit Toxicant Models of Parkinson’s Disease

Rudyk, C. (2018) · doi:10.22215/etd/2018-14444

Therapy of Parkinson’s disease-like deficits with rapamycin and trehalose in murine models with attenuated neuroinflammation

(2022) · International Multiconference on Bioinformatics of Genome Regulation and Structure / Systems Biology (BGRS/SB) · doi:10.18699/sbb-2022-419

Coixol ameliorates dopaminergic neurodegeneration by inhibiting neuroinflammation and protecting mitochondrial function

Yang, S., Han, J., Xue, M., Zhang, Y., Yan, A., Gao, X., He, J., Sun, X., Fu, S., Liu, D., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1657910

Neuroprotective Effects of Fluoxetine Derivative 4-[3-Oxo-3-(2-trifluoromethyl-phenyl)-propyl]-morpholinium Chloride (OTPM) as a Potent Modulator of Motor Deficits and Neuroinflammatory Pathways in LPS-Induced BV-2 Microglial Cells and MPTP-Induced Parkinsonian Models

Kang, S.-M., Balakrishnan, R., Ko, H. M., Park, J.-Y., Kumar, H., Kim, B., Yoon, S.-H., & Choi, D.-K. (2025) · Pharmaceuticals · doi:10.3390/ph18121799

Nigral biochemical and structural alterations following subacute exposure to MPTP in mice

Henry, R., Agbon, A., Musa, S., & Oladele, S. B. (2026) · Toxicology Reports · doi:10.1016/j.toxrep.2026.102314

Role of Inflammation in MPTP-Induced Dopaminergic Neuronal Death

Przedborski, S. (2008) · doi:10.21236/ada494929

Depletion of microglia augments the dopaminergic neurotoxicity of MPTP

Yang, X., Ren, H., Wood, K., Li, M., Qiu, S., Shi, F., Ma, C., & Liu, Q. (2018) · The FASEB Journal · doi:10.1096/fj.201700833rr · Cited by 115 · see citing works

Interleukin 4-induced neuroprotection and regulation of microglia activation as a therapeutic approach in the MPTP model of Parkinson's disease

Spittau, B. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.215250 · Cited by 23 · see citing works

Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation

Kempuraj, D., Selvakumar, G. P., Thangavel, R., Ahmed, M. E., Zaheer, S. A., Kumar, K., Yelam, A., Kaur, H., Dubova, I., Raikwar, S. P., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180786 · Cited by 34 · see citing works

MIF downregulation attenuates neuroinflammation via TLR4/MyD88/TRAF6/NF-κB pathway to protect dopaminergic neurons in Parkinson’s disease model

Huang, Y., Zhou, C., & Qu, S. (2025) · Communications Biology · doi:10.1038/s42003-025-08997-7 · Cited by 9 · see citing works